Research ArticleCancer
Therapeutic targeting of casein kinase 1δ in breast cancer
- Laura H. Rosenberg1,2,
- Marie Lafitte1,
- Victor Quereda1,
- Wayne Grant1,
- Weimin Chen1,
- Mathieu Bibian3,
- Yoshihiko Noguchi3,
- Mohammad Fallahi4,
- Chunying Yang5,6,
- Jenny C. Chang7,
- William R. Roush3,
- John L. Cleveland5,6 and
- Derek R. Duckett1,*
- 1Department of Molecular Therapeutics, The Scripps Research Institute, Jupiter, FL 33458, USA.
- 2Cancer Research Technology Discovery Laboratories, Jonas Webb Building, Babraham Research Campus, Cambridge, CB22 3AT, UK.
- 3Department of Chemistry, The Scripps Research Institute, Jupiter, FL 33458, USA.
- 4Informatics Core, The Scripps Research Institute, Jupiter, FL 33458, USA.
- 5Department of Cancer Biology, The Scripps Research Institute, Jupiter, FL 33458, USA.
- 6Department of Tumor Biology, Moffitt Cancer Center and Research Institute, Tampa, FL 33612, USA.
- 7Methodist Cancer Center, Houston Methodist Hospital, 6445 Main Street, P21-34, Houston, TX 77030, USA.
- ↵*Corresponding author. E-mail: ducketdr{at}scripps.edu
See allHide authors and affiliations
Science Translational Medicine 16 Dec 2015:
Vol. 7, Issue 318, pp. 318ra202
DOI: 10.1126/scitranslmed.aac8773
